Clinical Trials Browser

Glioblastoma

Brain Neoplasms

Glioblastoma

Diffuse Intrinsic Pontine Glioma

Brain Neoplasms, Breast Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Brain Neoplasms, Glioblastoma

Neuroma, Acoustic

Glioblastoma, Recurrence

Glioblastoma

Brain Neoplasms, Glioblastoma

Neoplasm Metastasis, Paraganglioma, Extra-Adrenal, Pheochromocytoma

Paraganglioma, Pheochromocytoma

Paraganglioma, Pheochromocytoma

Glioblastoma

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

Central Nervous System Diseases, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Neoplasms, Neuroblastoma, Neuroectodermal Tumors

Brain Neoplasms

Brain Neoplasms

Glioblastoma

Brain Neoplasms, Breast Neoplasms

Meningeal Carcinomatosis

Brain Neoplasms

Brain Neoplasms, Breast Neoplasms

Brain Neoplasms, Lung Neoplasms

Glioblastoma

Brain Neoplasms

Brain Neoplasms

Brain Neoplasms

Newly Diagnosed Glioblastoma

Glioblastoma

Paraganglioma, Pheochromocytoma

Ataxia, Medulloblastoma

Neuroblastoma

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Brain Neoplasms, Lung Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Brain Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Brain Neoplasms, Breast Neoplasms

Glioblastoma

Lung Neoplasms, Meningeal Carcinomatosis

Clinical Trials

TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.

NANORAD2

Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients

AGIR

Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade Gliomas

DIPG

Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases

CBC

ImPRESS

Nimodipine in Vestibular Schwanommas

TaRRGET

GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients

OptimalTTF-2

The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment

A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL

A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL

MRSI to Predict Response to RT/TMZ ± Belinostat in GBM

Furmonertinib in Patients With Leptomeningeal Metastases Associated With EGFR Mutated NSCLC

Aumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles

CILI

OPTIMUM

CAP-BRAIN

Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrence

Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas

IORT_BRAINM1

Phase 2 Study of CAN008 in Subjects With GBM

ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases

Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer

Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors

The Efficacy of HLX208 (BRAF V600E Inhibitor) for Refractory Primary Brain Tumors With BRAF Mutation After First-line Treatment

Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China

Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI.

SonoFIRST

HiSparCK

Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC

Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma

Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma

EASOAIPPGL

Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma Resection

Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma

TEMOTRAD01

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain Metastases

the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer

TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)

Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC

A-Plus

MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)

Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer